Ralph Laufer
Chief Tech/Sci/R&D Officer at LYSOGENE
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Karen Pignet-Aiach | F | 52 | 15 years | |
| Sol Barer | M | 76 | 9 years | |
| Côme de La Tour du Pin | M | - | 4 years | |
| Gerald Lieberman | M | 77 | 9 years | |
| Roberto Mignone | M | 52 | 7 years | |
| Peter Lichtlen | M | 56 | 6 years | |
| Rosemary Crane | F | 64 | 9 years | |
| Michel Picot | M | 72 | - | |
| Perry Nisen | M | 68 | 7 years | |
| Marie Deneux | M | - | - | |
| Carole Deffez | F | - | 5 years | |
| Céline Fantin | F | - | - | |
| Giancarlo Mocchi | M | 84 |
IRBM SpA
 IRBM SpA BiotechnologyHealth Technology IRBM SpA is a research organization that specializes in drug discovery and development. IRBM is based in Pomezia, IT, and has subsidiaries in Italy. The Italian company produces recombinant proteins in a homogeneous state and use cyclization to pre-organize compounds for target binding. The private company uses nuclear magnetic resonance (NMR) spectroscopy to study structural biology, clinical research solutions, functional genomics, structure/activity relationships, drug discovery, macromolecule, and small-molecule analysis. The company has a screening library of over 320,000 compounds and use virtual screening and NMR to drive innovation. The company was founded in 2010 by Piero di Lorenzo, who has been the CEO since then. | 25 years |
| Nir Baron | M | - | 10 years | |
| Marie Trad | M | - | 2 years |
Connections Chart
Multi-company connection
Former connections
Statistics
| Country | Connections | % of total |
|---|---|---|
| Israel | 77 | 81.05% |
| France | 17 | 17.89% |
| Italy | 1 | 1.05% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Ralph Laufer
- Personal Network